Global X Lithium & Battery Tech ETF vs Novavax Inc — how do they compare? Global X Lithium & Battery Tech ETF trades at $75.2, while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| LIT | NVAX | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $91.62 | $11.19 |
52-Week Low | $44.96 | $6.22 |
Market Cap | — | $1.31B |
Enterprise Value | — | $889.30M |
Trailing returns across standard periods
LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →